Bajaj HealthCare Limited (BOM:539872)

India · Delayed Price · Currency is INR

320.15

+2.65 (0.83%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Development, Manufacturing and Marketing of Active Pharmaceutical Ingredients	5.43B	4.73B	6.46B	6.80B	-
Development, Manufacturing and Marketing of Active Pharmaceutical Ingredients Growth	14.61%	-26.69%	-5.01%	-	-
Bulk Drugs	-	-	-	-	6.19B
Bulk Drugs Growth	-	-	-	-	52.08%
Formulations	-	-	-	-	657.28M
Formulations Growth	-	-	-	-	157.71%
Intersegment Revenue	-	-	-	-	-279.77M
Total	5.43B	4.73B	6.46B	6.80B	6.57B
Total Growth	14.61%	-26.69%	-5.01%	3.49%	59.96%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	4.18B	3.59B	4.44B	2.28B	4.39B
India Growth	16.50%	-19.10%	94.42%	-48.03%	38.48%
Outside India	1.24B	1.14B	2.02B	-	2.18B
Outside India Growth	8.69%	-43.40%	-	-	134.73%
Exports	-	-	-	4.52B	-
Total	5.43B	4.73B	6.46B	6.80B	6.57B
Total Growth	14.61%	-26.69%	-5.01%	3.49%	60.24%

Source: S&P Global Market Intelligence.